These disruptions in neurotransmitter function, alongside the reduced release of brain-derived neurotrophic factor (BDNF) in diabetes mellitus, further amplify the risk of CI in affected individuals (Ahmad et al., 2022). Here, BDNF is linked to diabetes mellitus.